STOCK TITAN
  1. Home
  2. Sec-filings
  3. LMAT
  4. [Form 4] LEMAITRE VASCULAR INC Insider Trading Activity

LeMaitre (NASDAQ: LMAT) director awarded new dividend equivalent rights

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC director Lawrence J. Jasinski reported routine compensation-related grants of dividend equivalent rights. On March 26, 2026, he acquired several small fractional awards of dividend equivalent rights linked to existing restricted stock unit and performance share unit grants from December 8, 2023, December 6, 2024, and December 10, 2025. Each dividend equivalent right is the economic equivalent of one share of LeMaitre Vascular common stock and will vest proportionately with the underlying stock or performance awards. These are non-cash, derivative awards and do not represent any open-market share purchases or sales.

Positive

  • None.

Negative

  • None.
Insider Jasinski Lawrence J
Role Director
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights 0.394 $0.00 --
Grant/Award Dividend Equivalent Rights 0.472 $0.00 --
Grant/Award Dividend Equivalent Rights 0.643 $0.00 --
Grant/Award Dividend Equivalent Rights 0.728 $0.00 --
Grant/Award Dividend Equivalent Rights 1.208 $0.00 --
Holdings After Transaction: Dividend Equivalent Rights — 4.602 shares (Direct)
Footnotes (1)
  1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent Rights grant 0.3941 rights Granted on March 26, 2026, economic equivalent of common stock
Dividend Equivalent Rights grant 0.4720 rights Granted on March 26, 2026, tied to prior equity award
Dividend Equivalent Rights grant 0.6426 rights Granted on March 26, 2026 as derivative compensation
Dividend Equivalent Rights grant 0.7276 rights Granted on March 26, 2026, vests with underlying award
Dividend Equivalent Rights grant 1.2077 rights Granted on March 26, 2026, economic equivalent of shares
Transactions acquiring rights 5 derivative entries All coded A for grant/award on March 26, 2026
Net buy/sell shares 0 shares transactionSummary netBuySellShares neutral in this Form 4
Dividend Equivalent Rights financial
"These dividend equivalent rights accrued on a restricted stock unit award"
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
restricted stock unit financial
"accrued on a restricted stock unit award granted on 12/8/2023"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
performance share unit financial
"accrued on a performance share unit award granted on 12/8/2023"
A performance share unit (PSU) is a form of executive or employee pay that promises shares (or the cash value of shares) only if the company meets specific performance targets over a set period. Think of it like a bonus cheque that only arrives if the company hits agreed goals — it aligns managers’ rewards with business results and signals to investors how leadership is being incentivized to grow value over time.
economic equivalent financial
"Each dividend equivalent right is the economic equivalent of one share"
derivative financial
"transaction_type": "derivative""
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jasinski Lawrence J
(Last)(First)(Middle)
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
(Street)
BURLINGTON MASSACHUSETTS 01803
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Dividend Equivalent Rights(1)03/26/2026A0.3941 (1) (1)Common Stock0.3941$04.6016D
Dividend Equivalent Rights(2)03/26/2026A0.472 (2) (2)Common Stock0.472$04.3113D
Dividend Equivalent Rights(3)03/26/2026A0.6426 (3) (3)Common Stock0.6426$03.5389D
Dividend Equivalent Rights(4)03/26/2026A0.7276 (4) (4)Common Stock0.7276$03.6239D
Dividend Equivalent Rights(5)03/26/2026A1.2077 (5) (5)Common Stock1.2077$01.2077D
Explanation of Responses:
1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
/s/ Laurie A. Churchill, Attorney-in-fact03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did LMAT director Lawrence Jasinski report?

Lawrence J. Jasinski reported acquiring several small grants of Dividend Equivalent Rights on March 26, 2026. These awards are tied to prior restricted stock unit and performance share unit grants and are part of his equity-based director compensation, not market purchases or sales.

What are Dividend Equivalent Rights in the LMAT Form 4 filing?

Dividend Equivalent Rights give the holder economic value similar to LMAT common stock dividends. In this filing, each right is the economic equivalent of one common share and accrues on existing restricted stock unit and performance share unit awards, vesting proportionately with those underlying grants over time.

Were any LMAT common shares bought or sold in this Form 4?

No LMAT common shares were bought or sold in this Form 4. The reported transactions involve derivative compensation awards (Dividend Equivalent Rights) credited at a price of $0.0000 per right, reflecting routine equity-based compensation rather than open-market trading activity.

Which prior LMAT equity awards generated these Dividend Equivalent Rights?

The Dividend Equivalent Rights accrued on LMAT awards granted on December 8, 2023, December 6, 2024, and December 10, 2025. They are linked to both restricted stock unit and performance share unit grants and will vest in step with those underlying awards as they vest.

How many Dividend Equivalent Rights did Jasinski acquire in each LMAT grant?

Jasinski acquired fractional amounts of Dividend Equivalent Rights in several grants, including 0.3941, 0.4720, 0.6426, 0.7276, and 1.2077 rights. Each fractional right corresponds economically to the same fraction of a share of LMAT common stock.